Nebenwirkungen · Remicade
Remicade 100 mg powder for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 18
HOS-089904 · Präparat HOS-083941
In post-marketing spontaneous reporting, infections are the most common serious adverse reaction. Some of the cases have resulted in a fatal outcome. Nearly 50% of reported deaths have been associated with infection. Cases of tuberculosis, sometimes fatal, including miliary tuberculosis and tuberculosis with extra-pulmonary location have been reported (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-15T13:59:00Z · SHA-256 3fe5ec643ebd8b47f3d2adf8a19ade1224c614e70c07c2d563b0cf68054693ab · Passage 76f2091fb2314ab8deeed555f3eab506c828e49fa44d54323a0936e88c5daa28 · Zeichen 17159–17531 im Abschnitt